WEARABLE DEVICES HAVE SENSORS THAT MONITOR THE SYMPTOMS OF PEOPLE WITH PD
now able to control their medical devices via mobile smartphone apps – including remote insulin dosing!
The t:sport pump from Tandem, for example, is a micro-pump hybrid that’s about half the size of the t:slim X2 pump but doesn’t have the display screen. The pump is half the size of the t:slim, which is already fairly sleek as far as insulin pumps go, and means that pump users don’t have to look at - or even touch - their insulin pump in order to order a bolus or change their delivery settings: a huge win for discretion and ease-of-use.
Known as a Flash Glucose Monitoring (FGM) Trusted Source system, the FreeStyle Libre from Abbott Diabetes provides a ‘flash’ of a glucose reading whenever the patient scans the sensor with the handheld receiver or smartphone app; thereby generating a real-time glucose reading every minute and displaying the result on the compatible mobile app on iPhone or Android.
Roche has also taken its first step in the field of automated insulin delivery (AID) by teaming up with French MedTech company, Diabeloop, to advance the management of insulin pump therapy. Diabeloop’s solutions embed self-learning algorithms to personalise – to the physiology and lifestyle of patients - diabetes management.
When it comes to conditions such as Parkinson’s disease (PD), the National Institute for Health and Care Excellence (NICE) has recommended that the NHS collects real-world evidence on devices that monitor people with PD.
and continues to produce – new products to assist patients in the self-management of their conditions.
With diabetes, for example, as the number of people with diabetes continues to grow – again as a result of the ageing population - the number of automated and medical devices designed to control the condition are expanding incrementally.
One of the most exciting developments in the world of diabetes is that people with diabetes are
In fact, NICE has actually recommended five promising technologies that could help improve symptoms and quality of life for people with PD: The wearable devices have sensors that monitor the symptoms of people with PD. The information provided by the devices may more accurately record a person’s symptoms than a clinical assessment during in-person appointments and, as such, can help inform medication decisions and follow up treatment such as physiotherapy.
The five devices are: • The Personal KinetiGraph Movement Recording System: A watch that measures movement and is intended to quantify
movement disorder symptoms, including tremor, involuntary movement, and slowness.
• STAT-ON: A waist-worn inertia recorder, which measures motor disorders and events when worn by someone with PD but does not measure tremor. The device measures involuntary movement, how people walk (including slowness and freezing of gait), falls, energy expenditure and posture.
• Kinesia 360: The device monitors physical motion and muscle activity to analyse how people are able to move and how their condition is progressing. Sensors record data all day and recharge overnight for extended home use. The app also includes electronic diaries for capturing patient-reported outcomes and customisable medication diaries.
• KinesiaU: The KinesiaU measures tremor, slowness and involuntary movement using a smartwatch and smartphone app. Patients can view reports in real-time and share these with their healthcare professionals.
• PDMonitor: In this system, activity/posture, slowness, gait disturbances, freezing of gait, wrist tremor, leg tremor, involuntary movement and on and off periods are all measured. The devices are worn on both wrists, ankles and one is worn on the waist, and acquire movement data for assessing motor symptoms.
USERS DON’T HAVE TO LOOK AT - OR EVEN TOUCH - THEIR INSULIN PUMP IN ORDER TO ORDER A BOLUS OR CHANGE THEIR DELIVERY SETTINGS
scottishpharmacist.com 25
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
